How could retinoids fit into Alzheimer's therapy?

Drugs of the Future

Volumn 41, Issue 1, 2016, Pages 15-23

  Steardo, L ^a   Signorile, A ^b   Scuderi, C ^c   Carratu M R ^b  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF BARI   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Alzheimer's disease; Amyloid cascade; Cerebral microvessels; Cognitive decline; Neuroinflammation; Oxidative stress; Retinoids; Therapeutic strategy

Indexed keywords

AMYLOID BETA PROTEIN; RETINOID;

ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; COGNITIVE DEFECT; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG MECHANISM; DRUG PROTEIN BINDING; HUMAN; NERVE DEGENERATION; NERVE REGENERATION; NERVOUS SYSTEM INFLAMMATION; NEUROFIBRILLARY TANGLE; NEUROTRANSMISSION; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; REVIEW; SENILE PLAQUE; SIGNAL TRANSDUCTION;

EID: 84962382997     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.2016.041.01.2401820     Document Type: Review

References (149)

1. Blennow, K., de leon, M.J., Zetterberg, H. Alzheimer's disease. lancet 2006, 368(9533): 387-403.
2. Speck-Planche, A., luan, F., Cordeiro, M.N. Role of ligand-based drug design methodologies toward the discovery of new anti-Alzheimer agents: futures perspectives in Fragment-Based Ligand Design. Curr Med Chem 2012, 19(11): 1635-45.
3. Hardy, J.A., Higgins, G.A. Alzheimer's disease: the amyloid cascade hypothesis. Science 1992, 256(5054): 184-5.
4. Parker, w.D., Jr., Filley, C.M., Parks, J.K. Cytochrome oxidase deficiency in Alzheimer's disease. Neurology 1990, 40(8): 1302-3.
5. Hirai, K., Aliev, G., Nunomura, A. et al. Mitochondrial abnormalities in Alzheimer's disease. J Neurosci 2001, 21(9): 3017-23.
6. wang, X., Su, B., lee, H.G., li, X., Perry, G., Smith, M.A., Zhu, X. Impaired balance of mitochondrial fission and fusion in Alzheimer's disease. J Neurosci 2009, 29(28): 9090-103.
7. wang, X., Su, B., Siedlak, S.l. et al. Amyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins. Proc Natl Acad Sci U S A 2008, 105(49): 19318-23.
8. Carratu, M.R., Marasco, C., Signorile, A., Scuderi, C., Steardo, l. Are retinoids a promise for Alzheimer's disease management? Curr Med Chem 2012, 19(36): 6119-25.
9. wang, J.Z., wang, Z.H., Tian, Q. Tau hyperphosphorylation induces apoptotic escape and triggers neurodegeneration in Alzheimer's disease. Neurosci Bull 2014, 30(2): 359-66.
10. Orhan, I.E. Current concepts on selected plant secondary metabolites with promising inhibitory effects against enzymes linked to Alzheimer's disease. Curr Med Chem 2012, 19(14): 2252-61.
11. wyss-Coray, T. Inflammation in Alzheimer disease: driving force, bystander or beneficial response Nat Med 2006, 12(9): 1005-15.
12. Cooper, N.R., Bradt, B.M., O'Barr, S., Yu, J.X. Focal inflammation in the brain: role in Alzheimer's disease. Immunol Res 2000, 21(2-3): 159-65.
13. McGeer, P.l., McGeer, E.G. Inflammation and the degenerative diseases of aging. Ann N Y Acad Sci 2004, 1035: 104-16.
14. lee, Y.J., Han, S.B., Nam, S.Y., Oh, K.w., Hong, J.T. Inflammation and Alzheimer's disease. Arch Pharm Res 2010, 33(10): 1539-56.
15. Shimizu, E., Kawahara, K., Kajizono, M., Sawada, M., Nakayama, H. IL-4-induced selective clearance of oligomeric beta-Amyloid peptide(1-42) by rat primary type 2 microglia. J Immunol 2008, 181(9): 6503-13.
16. Kawahara, K., Suenobu, M., Yoshida, A. et al. Intracerebral microinjection of interleukin-4/interleukin-13 reduces beta-Amyloid accumulation in the ipsilateral side and improves cognitive deficits in young amyloid precursor protein 23 mice. Neuroscience 2012, 207: 243-60.
17. Dong, Y., Benveniste, E.N. Immune function of astrocytes. Glia 2001, 36(2): 180-90.
18. Steardo, l., Jr., Bronzuoli, M.R., Iacomino, A., Esposito, G., Steardo, l., Scuderi, C. Does neuroinflammation turn on the flame in Alzheimer's disease Focus on astrocytes. Front Neurosci 2015, 9: 259.
19. Tehranian, R., Hasanvan, H., Iverfeldt, K., Post, C., Schultzberg, M. Early induction of interleukin-6 mRNA in the hippocampus and cortex of APPsw transgenic mice Tg2576. Neurosci lett 2001, 301(1): 54-8.
20. Frohman, E.M., Frohman, T.C., Gupta, S., de Fougerolles, A., van den Noort, S. Expression of intercellular adhesion molecule 1 (ICAM-1) in Alzheimer's disease. J Neurol Sci 1991, 106(1): 105-11.
21. Dorheim, M.A., Tracey, w.R., Pollock, J.S., Grammas, P. Nitric oxide synthase activity is elevated in brain microvessels in Alzheimer's disease. Biochem Biophys Res Commun 1994, 205(1): 659-65.
22. Grammas, P., Ovase, R. Inflammatory factors are elevated in brain microvessels in Alzheimer's disease. Neurobiol Aging 2001, 22(6): 837-42.
23. Grammas, P., Ovase, R. Cerebrovascular transforming growth factor-beta contributes to inflammation in the Alzheimer's disease brain. Am J Pathol 2002, 160(5): 1583-7.
24. li, M., Shang, D.S., Zhao, w.D. et al. Amyloid beta interaction with receptor for advanced glycation end products up-regulates brain endothelial CCR5 expression and promotes T cells crossing the blood-brain barrier. J Immunol 2009, 182(9): 5778-88.
25. vukic, v., Callaghan, D., walker, D. et al. Expression of inflammatory genes induced by beta-Amyloid peptides in human brain endothelial cells and in Alzheimer's brain is mediated by the JNK-AP1 signaling pathway. Neurobiol Dis 2009, 34(1): 95-106.
26. Nunomura, A., Castellani, R.J., Zhu, X., Moreira, P.I., Perry, G., Smith, M.A. Involvement of oxidative stress in Alzheimer disease. J Neuropathol Exp Neurol 2006, 65(7): 631-41.
27. Bogdanovic, N., Zilmer, M., Zilmer, K., Rehema, A., Karelson, E. The Swedish APP670/671 Alzheimer's disease mutation: the first evidence for strikingly increased oxidative injury in the temporal inferior cortex. Dement Geriatr Cogn Disord 2001, 12(6): 364-70.
28. Pratico, D., Uryu, K., leight, S., Trojanoswki, J.Q., lee, v.M. Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. J Neurosci 2001, 21(12): 4183-7.
29. Baloyannis, S.J. Mitochondrial alterations in Alzheimer's disease. J Alzheimers Dis 2006, 9(2): 119-26.
30. Pavlov, P.F., wiehager, B., Sakai, J., Frykman, S., Behbahani, H., winblad, B., Ankarcrona, M. Mitochondrial gamma-secretase participates in the metabolism of mitochondria-Associated amyloid precursor protein. FASEB J 2011, 25(1): 78-88.
31. Morsch, R., Simon, w., Coleman, P.D. Neurons may live for decades with neurofibrillary tangles. J Neuropathol Exp Neurol 1999, 58(2): 188-97.
32. Manning-Bog, A.B., McCormack, A.l., Purisai, M.G., Bolin, l.M., Di Monte, D.A. Alpha-synuclein overexpression protects against paraquatinduced neurodegeneration. J Neurosci 2003, 23(8): 3095-9.
33. Arrasate, M., Mitra, S., Schweitzer, E.S., Segal, M.R., Finkbeiner, S. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 2004, 431(7010): 805-10.
34. Giuffrida, M.l., Caraci, F., Pignataro, B. et al. Beta-Amyloid monomers are neuroprotective. J Neurosci 2009, 29(34): 10582-7.
35. Giuffrida, M.l., Caraci, F., De Bona, P., Pappalardo, G., Nicoletti, F., Rizzarelli, E., Copani, A. The monomer state of beta-Amyloid: where the Alzheimer's disease protein meets physiology. Rev Neurosci 2010, 21(2): 83-93.
36. wang, J.Z. Alzheimer's disease: from molecule to clinic. Neurosci Bull 2014, 30(2): 169-71.
37. wang, J.Z., Xia, Y.Y., Grundke-Iqbal, I., Iqbal, K. Abnormal hyperphosphorylation of tau: sites, regulation, and molecular mechanism of neurofibrillary degeneration. J Alzheimers Dis 2013, 33 Suppl 1: S123-39.
38. Arif, M., wei, J., Zhang, Q., liu, F., Basurto-Islas, G., Grundke-Iqbal, I., Iqbal, K. Cytoplasmic retention of protein phosphatase 2A inhibitor 2 (I2PP2A) induces Alzheimer-like abnormal hyperphosphorylation of Tau. J Biol Chem 2014, 289(40): 27677-91.
39. wang, X., Blanchard, J., Tung, Y.C., Grundke-Iqbal, I., Iqbal, K. Inhibition of protein phosphatase-2A (PP2A) by I1PP2A leads to hyperphosphor-ylation of tau, neurodegeneration, and cognitive impairment in rats. J Alzheimers Dis 2015, 45(2): 423-35.
40. Chabrier, M.A., Cheng, D., Castello, N.A., Green, K.N., laFerla, F.M. Synergistic effects of amyloid-beta and wild-type human tau on dendritic spine loss in a floxed double transgenic model of Alzheimer's disease. Neurobiol Dis 2014, 64: 107-17.
41. Gregori, l., Hainfeld, J.F., Simon, M.N., Goldgaber, D. Binding of amyloid beta protein to the 20 S proteasome. J Biol Chem 1997, 272(1): 58-62.
42. Balmer, J.E., Blomhoff, R. Gene expression regulation by retinoic acid. J lipid Res 2002, 43(11): 1773-808.
43. leid, M., Kastner, P., Chambon, P. Multiplicity generates diversity in the retinoic acid signalling pathways. Trends Biochem Sci 1992, 17(10): 427-33.
44. Chambon, P. The nuclear receptor superfamily: a personal retrospect on the first two decades. Mol Endocrinol 2005, 19(6): 1418-28.
45. Theodosiou, M., laudet, v., Schubert, M. From carrot to clinic: an over-view of the retinoic acid signaling pathway. Cell Mol life Sci 2010, 67(9): 1423-45.
46. Chen, N., Onisko, B., Napoli, J.l. The nuclear transcription factor RARalpha associates with neuronal RNA granules and suppresses translation. J Biol Chem 2008, 283(30): 20841-7.
47. Poon, M.M., Chen, l. Retinoic acid-gated sequence-specific translational control by RARalpha. Proc Natl Acad Sci U S A 2008, 105(51): 20303-8.
48. liao, Y.P., Ho, S.Y., liou, J.C. Non-genomic regulation of transmitter release by retinoic acid at developing motoneurons in Xenopus cell culture. J Cell Sci 2004, 117(Pt 14): 2917-24.
49. Masia, S., Alvarez, S., de lera, A.R., Barettino, D. Rapid, nongenomic actions of retinoic acid on phosphatidylinositol-3-kinase signaling pathway mediated by the retinoic acid receptor. Mol Endocrinol 2007, 21(10): 2391-402.
50. liou, J.C., Ho, S.Y., Shen, M.R., liao, Y.P., Chiu, w.T., Kang, K.H. A rapid, nongenomic pathway facilitates the synaptic transmission induced by retinoic acid at the developing synapse. J Cell Sci 2005, 118(Pt 20): 4721-30.
51. Fanjul, A., Dawson, M.I., Hobbs, P.D. et al. A new class of retinoids with selective inhibition of AP-1 inhibits proliferation. Nature 1994, 372(6501): 107-11.
52. Baeuerle, P.A., Baltimore, D. NF-kappa B: ten years after. Cell 1996, 87(1): 13-20.
53. Austenaa, l.M., Carlsen, H., Ertesvag, A., Alexander, G., Blomhoff, H.K., Blomhoff, R. Vitamin A status significantly alters nuclear factor-kappaB activity assessed by in vivo imaging. FASEB J 2004, 18(11): 1255-7.
54. Austenaa, l.M., Carlsen, H., Hollung, K., Blomhoff, H.K., Blomhoff, R. Retinoic acid dampens LPS-induced NF-kappaB activity: results from human monoblasts and in vivo imaging of NF-kappaB reporter mice. J Nutr Biochem 2009, 20(9): 726-34.
55. Aggarwal, S., Kim, S.w., Cheon, K., Tabassam, F.H., Yoon, J.H., Koo, J.S. Nonclassical action of retinoic acid on the activation of the cAMP response element-binding protein in normal human bronchial epithelial cells. Mol Biol Cell 2006, 17(2): 566-75.
56. Ochoa, w.F., Torrecillas, A., Fita, I., verdaguer, N., Corbalan-Garcia, S., Gomez-Fernandez, J.C. Retinoic acid binds to the C2-domain of protein kinase C(alpha). Biochemistry 2003, 42(29): 8774-9.
57. Maden, M. Retinoic acid in the development, regeneration and maintenance of the nervous system. Nat Rev Neurosci 2007, 8(10): 755-65.
58. Niederreither, K., Dolle, P. Retinoic acid in development: towards an integrated view. Nat Rev Genet 2008, 9(7): 541-53.
59. Duester, G. Retinoic acid synthesis and signaling during early organogenesis. Cell 2008, 134(6): 921-31.
60. De luca, l.M. Retinoids and their receptors in differentiation, embryogenesis, and neoplasia. FASEB J 1991, 5(14): 2924-33.
61. Altucci, l., Gronemeyer, H. The promise of retinoids to fight against cancer. Nat Rev Cancer 2001, 1(3): 181-93.
62. Maden, M., Hind, M. Retinoic acid, a regeneration-inducing molecule. Dev Dyn 2003, 226(2): 237-44.
63. Olson, C.R., Mello, C.v. Significance of vitamin A to brain function, behavior and learning. Mol Nutr Food Res 2010, 54(4): 489-95.
64. Fisher, C.M. 'Catatonia' due to disulfiram toxicity. Arch Neurol 1989, 46(7): 798-804.
65. McCaffery, P., Drager, U.C. High levels of a retinoic acid-generating dehydrogenase in the meso-telencephalic dopamine system. Proc Natl Acad Sci U S A 1994, 91(16): 7772-6.
66. Corcoran, J.P., So, P.l., Maden, M. Disruption of the retinoid signalling pathway causes a deposition of amyloid beta in the adult rat brain. Eur J Neurosci 2004, 20(4): 896-902.
67. lee, H.P., Casadesus, G., Zhu, X. et al. All-trans retinoic acid as a novel therapeutic strategy for Alzheimer's disease. Expert Rev Neurother 2009, 9(11): 1615-21.
68. Corcoran, J., So, P.l., Maden, M. Absence of retinoids can induce motoneuron disease in the adult rat and a retinoid defect is present in motoneuron disease patients. J Cell Sci 2002, 115(Pt 24): 4735-41.
69. Galter, D., Buervenich, S., Carmine, A., Anvret, M., Olson, l. ALDH1 mRNA: presence in human dopamine neurons and decreases in substantia nigra in Parkinson's disease and in the ventral tegmental area in schizophrenia. Neurobiol Dis 2003, 14(3): 637-47.
70. Hull, P.R., D'Arcy, C. Isotretinoin use and subsequent depression and suicide: presenting the evidence. Am J Clin Dermatol 2003, 4(7): 493-505.
71. Shudo, K., Fukasawa, H., Nakagomi, M., Yamagata, N. Towards retinoid therapy for Alzheimer's disease. Curr Alzheimer Res 2009, 6(3): 302-11.
72. lane, M.A., Bailey, S.J. Role of retinoid signalling in the adult brain. Prog Neurobiol 2005, 75(4): 275-93.
73. Chiang, M.Y., Misner, D., Kempermann, G. et al. An essential role for retinoid receptors RARbeta and RXRgamma in long-term potentiation and depression. Neuron 1998, 21(6): 1353-61.
74. Misner, D.l., Jacobs, S., Shimizu, Y. et al. Vitamin A deprivation results in reversible loss of hippocampal long-term synaptic plasticity. Proc Natl Acad Sci U S A 2001, 98(20): 11714-9.
75. Etchamendy, N., Enderlin, v., Marighetto, A., vouimba, R.M., Pallet, v., Jaffard, R., Higueret, P. Alleviation of a selective age-related relational memory deficit in mice by pharmacologically induced normalization of brain retinoid signaling. J Neurosci 2001, 21(16): 6423-9.
76. Mingaud, F., Mormede, C., Etchamendy, N. et al. Retinoid hyposignaling contributes to aging-related decline in hippocampal function in shortterm/working memory organization and long-term declarative memory encoding in mice. J Neurosci 2008, 28(1): 279-91.
77. Etchamendy, N., Enderlin, v., Marighetto, A., Pallet, v., Higueret, P., Jaffard, R. Vitamin A deficiency and relational memory deficit in adult mice: relationships with changes in brain retinoid signalling. Behav Brain Res 2003, 145(1-2): 37-49.
78. lucarelli, E., Kaplan, D.R., Thiele, C.J. Selective regulation of TrkA and TrkB receptors by retinoic acid and interferon-gamma in human neuroblastoma cell lines. J Biol Chem 1995, 270(42): 24725-31.
79. Bulens, F., Ibanez-Tallon, I., van Acker, P., De vriese, A., Nelles, l., Belayew, A., Collen, D. Retinoic acid induction of human tissue-type plasminogen activator gene expression via a direct repeat element (DR5) located at-7 kilobases. J Biol Chem 1995, 270(13): 7167-75.
80. Melchor, J.P., Strickland, S. Tissue plasminogen activator in central nervous system physiology and pathology. Thromb Haemost 2005, 93(4): 655-60.
81. Pang, P.T., Teng, H.K., Zaitsev, E. et al. Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity. Science 2004, 306(5695): 487-91.
82. Brouillette, J., Quirion, R. Transthyretin: a key gene involved in the maintenance of memory capacities during aging. Neurobiol Aging 2008, 29(11): 1721-32.
83. Monaco, H.l. The transthyretin-retinol-binding protein complex. Biochim Biophys Acta 2000, 1482(1-2): 65-72.
84. wisniewski, T., Castano, E., Ghiso, J., Frangione, B. Cerebrospinal fluid inhibits Alzheimer beta-Amyloid fibril formation in vitro. Ann Neurol 1993, 34(4): 631-3.
85. Strittmatter, w.J., weisgraber, K.H., Huang, D.Y. et al. Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci U S A 1993, 90(17): 8098-102.
86. Ghiso, J., Matsubara, E., Koudinov, A., Choi-Miura, N.H., Tomita, M., wisniewski, T., Frangione, B. The cerebrospinal-fluid soluble form of Alzheimer's amyloid beta is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-Attack complex. Biochem J 1993, 293(Pt. 1): 27-30.
87. Merched, A., Serot, J.M., visvikis, S., Aguillon, D., Faure, G., Siest, G. Apolipoprotein E, transthyretin and actin in the CSF of Alzheimer's patients: relation with the senile plaques and cytoskeleton biochemistry. FEBS lett 1998, 425(2): 225-8.
88. velayudhan, l., Killick, R., Hye, A. et al. Plasma transthyretin as a candidate marker for Alzheimer's disease. J Alzheimers Dis 2012, 28(2): 369-75.
89. Schultz, K., Nilsson, K., Nielsen, J.E. et al. Transthyretin as a potential CSF biomarker for Alzheimer's disease and dementia with Lewy bodies: effects of treatment with cholinesterase inhibitors. Eur J Neurol 2010, 17(3): 456-60.
90. li, X., Masliah, E., Reixach, N., Buxbaum, J.N. Neuronal production of transthyretin in human and murine Alzheimer's disease: is it protective J Neurosci 2011, 31(35): 12483-90.
91. Cuenco, K.T., Friedland, R., Baldwin, C.T. et al. Association of TTR polymorphisms with hippocampal atrophy in Alzheimer disease families. Neurobiol Aging 2011, 32(2): 249-56.
92. Jacobs, S., lie, D.C., DeCicco, K.l., Shi, Y., Deluca, l.M., Gage, F.H., Evans, R.M. Retinoic acid is required early during adult neurogenesis in the dentate gyrus. Proc Natl Acad Sci U S A 2006, 103(10): 3902-7.
93. Jin, K., Peel, A.l., Mao, X.O., Xie, l., Cottrell, B.A., Henshall, D.C., Greenberg, D.A. Increased hippocampal neurogenesis in Alzheimer's disease. Proc Natl Acad Sci U S A 2004, 101(1): 343-7.
94. Ding, Y., Qiao, A., wang, Z. et al. Retinoic acid attenuates beta-Amyloid deposition and rescues memory deficits in an Alzheimer's disease transgenic mouse model. J Neurosci 2008, 28(45): 11622-34.
95. Satoh, J., Kuroda, Y. Amyloid precursor protein beta-secretase (BACE) mRNA expression in human neural cell lines following induction of neuronal differentiation and exposure to cytokines and growth factors. Neuropathology 2000, 20(4): 289-96.
96. Yang, Y., Quitschke, w.w., Brewer, G.J. Upregulation of amyloid precursor protein gene promoter in rat primary hippocampal neurons by phorbol ester, IL-1 and retinoic acid, but not by reactive oxygen species. Brain Res Mol Brain Res 1998, 60(1): 40-9.
97. Murray, J.N., Igwe, O.J. Regulation of beta-Amyloid precursor protein and inositol 1,4,5-trisphosphate receptor gene expression during differentiation of a human neuronal cell line. Prog Neuropsychopharmacol Biol Psychiatry 2003, 27(3): 351-63.
98. Hong, C.S., Caromile, l., Nomata, Y., Mori, H., Bredesen, D.E., Koo, E.H. Contrasting role of presenilin-1 and presenilin-2 in neuronal differentiation in vitro. J Neurosci 1999, 19(2): 637-43.
99. Koryakina, A., Aeberhard, J., Kiefer, S., Hamburger, M., Kuenzi, P. Regulation of secretases by all-trans-retinoic acid. FEBS J 2009, 276(9): 2645-55.
100. 100.Schindowski, K., Bretteville, A., leroy, K., Begard, S., Brion, J.P., Hamdane, M., Buee, l. Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits. Am J Pathol 2006, 169(2): 599-616.
101. lovestone, S., Reynolds, C.H. The phosphorylation of tau: a critical stage in neurodevelopment and neurodegenerative processes. Neuroscience 1997, 78(2): 309-24.
102. 102.Jonsson, T., Atwal, J.K., Steinberg, S. et al. A mutation in APP protects against Alzheimer's disease and age-related cognitive decline. Nature 2012, 488(7409): 96-9.
103. 103.Shudo, K., Kagechika, H., Yamazaki, N., Igarashi, M., Tateda, C. A synthetic retinoid Am80 (tamibarotene) rescues the memory deficit caused by scopolamine in a passive avoidance paradigm. Biol Pharm Bull 2004, 27(11): 1887-9.
104. 104.Berse, B., Blusztajn, J.K. Coordinated up-regulation of choline acetyltransferase and vesicular acetylcholine transporter gene expression by the retinoic acid receptor alpha, cAMP, and leukemia inhibitory factor/ciliary neurotrophic factor signaling pathways in a murine septal cell line. J Biol Chem 1995, 270(38): 22101-4.
105. 105.Samad, T.A., Krezel, w., Chambon, P., Borrelli, E. Regulation of dopaminergic pathways by retinoids: activation of the D2 receptor promoter by members of the retinoic acid receptor-retinoid X receptor family. Proc Natl Acad Sci U S A 1997, 94(26): 14349-54.
106. 106.Grimm, A., Schmitt, K., Eckert, A. Advanced Mitochondrial Respiration Assay for Evaluation of Mitochondrial Dysfunction in Alzheimer's Disease. Methods Mol Biol 2016, 1303: 171-83.
107. Selkoe, D.J. Alzheimer's disease is a synaptic failure. Science 2002, 298(5594): 789-91.
108. 108.Cotman, C.w., Su, J.H. Mechanisms of neuronal death in Alzheimer's disease. Brain Pathol 1996, 6(4): 493-506.
109. 109.Barinaga, M. Is apoptosis key in Alzheimer's disease Science 1998, 281(5381): 1303-4.
110. Mattson, M.P. Apoptosis in neurodegenerative disorders. Nat Rev Mol Cell Biol 2000, 1(2): 120-9.
111. Shimohama, S. Apoptosis in Alzheimer's disease-An update. Apoptosis 2000, 5(1): 9-16.
112. Fang, D., wang, Y., Zhang, Z. et al. Increased neuronal PreP activity reduces Abeta accumulation, attenuates neuroinflammation and improves mitochondrial and synaptic function in Alzheimer disease's mouse model. Hum Mol Genet 2015, 24(18): 5198-210.
113. Chen, J., Teixeira, P.F., Glaser, E., levine, R.l. Mechanism of oxidative inactivation of human presequence protease by hydrogen peroxide. Free Radic Biol Med 2014, 77: 57-63.
114. Mantymaa, P., Guttorm, T., Siitonen, T. et al. Cellular redox state and its relationship to the inhibition of clonal cell growth and the induction of apoptosis during all-trans retinoic acid exposure in acute myeloblastic leukemia cells. Haematologica 2000, 85(3): 238-45.
115. Zanotto-Filho, A., Schroder, R., Moreira, J.C. Xanthine oxidase-dependent ROS production mediates vitamin A pro-oxidant effects in cultured Sertoli cells. Free Radic Res 2008, 42(6): 593-601.
116. Kiningham, K.K., Cardozo, Z.A., Cook, C. et al. All-trans-retinoic acid induces manganese superoxide dismutase in human neuroblastoma through NF-kappaB. Free Radic Biol Med 2008, 44(8): 1610-6.
117. Ahlemeyer, B., Krieglstein, J. Inhibition of glutathione depletion by retinoic acid and tocopherol protects cultured neurons from staurosporine-induced oxidative stress and apoptosis. Neurochem Int 2000, 36(1): 1-5.
118. Jackson, G.R., Morgan, B.C., werrbach-Perez, K., Perez-Polo, J.R. Antioxidant effect of retinoic acid on PC12 rat pheochromocytoma. Int J Dev Neurosci 1991, 9(2): 161-70.
119. Sakabe, T., Tsuchiya, H., Endo, M. et al. An antioxidant effect by acyclic retinoid suppresses liver tumor in mice. Biochem Pharmacol 2007, 73(9): 1405-11.
120. 120.de Oliveira, M.R., da Rocha, R.F., Stertz, l., Fries, G.R., de Oliveira, D.l., Kapczinski, F., Moreira, J.C. Total and mitochondrial nitrosative stress, decreased brain-derived neurotrophic factor (BDNF) levels and glutamate uptake, and evidence of endoplasmic reticulum stress in the hippocampus of vitamin A-treated rats. Neurochem Res 2011, 36(3): 506-17.
121. Kuenzli, S., Tran, C., Saurat, J.H. Retinoid receptors in inflammatory responses: a potential target for pharmacology. Curr Drug Targets Inflamm Allergy 2004, 3(4): 355-60.
122. Zitnik, R.J., Kotloff, R.M., latifpour, J., Zheng, T., whiting, N.l., Schwalb, J., Elias, J.A. Retinoic acid inhibition of IL-1-induced IL-6 production by human lung fibroblasts. J Immunol 1994, 152(3): 1419-27.
123. Kagechika, H., Kawachi, E., Fukasawa, H. et al. Inhibition of IL-1-induced IL-6 production by synthetic retinoids. Biochem Biophys Res Commun 1997, 231(2): 243-8.
124. 124.Dheen, S.T., Jun, Y., Yan, Z., Tay, S.S., ling, E.A. Retinoic acid inhibits expression of TNF-Alpha and iNOS in activated rat microglia. Glia 2005, 50(1): 21-31.
125. 125.Kaur, C., Sivakumar, v., Dheen, S.T., ling, E.A. Insulin-like growth factor I and II expression and modulation in amoeboid microglial cells by lipopolysaccharide and retinoic acid. Neuroscience 2006, 138(4): 1233-44.
126. 126.Kampmann, E., Johann, S., van Neerven, S., Beyer, C., Mey, J. Anti-inflammatory effect of retinoic acid on prostaglandin synthesis in cultured cortical astrocytes. J Neurochem 2008, 106(1): 320-32.
127. Kawahara, K., Suenobu, M., Ohtsuka, H. et al. Cooperative therapeutic action of retinoic acid receptor and retinoid x receptor agonists in a mouse model of Alzheimer's disease. J Alzheimers Dis 2014, 42(2): 587-605.
128. 128.landreth, G.E., Cramer, P.E., lakner, M.M., Cirrito, J.R., wesson, D.w., Brunden, K.R., wilson, D.A. Response to comments on "ApoE-directed therapeutics rapidly clear beta-Amyloid and reverse deficits in AD mouse models". Science 2013, 340(6135): 924-g.
129. 129.weller, R.O., Preston, S.D., Subash, M., Carare, R.O. Cerebral amyloid angiopathy in the aetiology and immunotherapy of Alzheimer disease. Alzheimers Res Ther 2009, 1(2): 6.
130. 130.viswanathan, A., Greenberg, S.M. Cerebral amyloid angiopathy in the elderly. Ann Neurol 2011, 70(6): 871-80.
131. Yates, P.A., Sirisriro, R., villemagne, v.l., Farquharson, S., Masters, C.l., Rowe, C.C., Group, A.R. Cerebral microhemorrhage and brain beta-Amyloid in aging and Alzheimer disease. Neurology 2011, 77(1): 48-54.
132. Eng, J.A., Frosch, M.P., Choi, K., Rebeck, G.w., Greenberg, S.M. Clinical manifestations of cerebral amyloid angiopathy-related inflammation. Ann Neurol 2004, 55(2): 250-6.
133. Grammas, P. Neurovascular dysfunction, inflammation and endothelial activation: implications for the pathogenesis of Alzheimer's disease. J Neuroinflammation 2011, 8: 26.
134. Piazza, F., Greenberg, S.M., Savoiardo, M. et al. Anti-Amyloid beta autoantibodies in cerebral amyloid angiopathy-related inflammation: implications for amyloid-modifying therapies. Ann Neurol 2013, 73(4): 449-58.
135. Kimura, A., Sakurai, T., Yoshikura, N., Hayashi, Y., Takemura, M., Taka-hashi, H., Inuzuka, T. Corticosteroid therapy in a patient with cerebral amyloid angiopathy-related inflammation. J Neuroinflammation 2013, 10: 39.
136. van Neerven, S., Kampmann, E., Mey, J. RAR/RXR and PPAR/RXR signaling in neurological and psychiatric diseases. Prog Neurobiol 2008, 85(4): 433-51.
137. landreth, G. Therapeutic use of agonists of the nuclear receptor PPARgamma in Alzheimer's disease. Curr Alzheimer Res 2007, 4(2): 159-64.
138. 138.Bright, J.J., Kanakasabai, S., Chearwae, w., Chakraborty, S. PPAR regulation of inflammatory signaling in CNS diseases. PPAR Res 2008, 2008: 658520.
139. 139.wada, K., Nakajima, A., Katayama, K. et al. Peroxisome proliferator-Activated receptor gamma-mediated regulation of neural stem cell proliferation and differentiation. J Biol Chem 2006, 281(18): 12673-81.
140. 140.Bodles, A.M., Barger, S.w. Secreted beta-Amyloid precursor protein activates microglia via JNK and p38-MAPK. Neurobiol Aging 2005, 26(1): 9-16.
141. Ho, G.J., Drego, R., Hakimian, E., Masliah, E. Mechanisms of cell signaling and inflammation in Alzheimer's disease. Curr Drug Targets Inflamm Allergy 2005, 4(2): 247-56.
142. 142.Kapadia, R., Yi, J.H., vemuganti, R. Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists. Front Biosci 2008, 13: 1813-26.
143. 143.O'Banion, M.K. COX-2 and Alzheimer's disease: potential roles in inflammation and neurodegeneration. Expert Opin Investig Drugs 1999, 8(10): 1521-36.
144. 144.landreth, G.E., Heneka, M.T. Anti-inflammatory actions of peroxisome proliferator-Activated receptor gamma agonists in Alzheimer's disease. Neurobiol Aging 2001, 22(6): 937-44.
145. Feinstein, D.l. Therapeutic potential of peroxisome proliferator-Activated receptor agonists for neurological disease. Diabetes Technol Ther 2003, 5(1): 67-73.
146. 146.Esposito, G., Scuderi, C., valenza, M. et al. Cannabidiol reduces Abetainduced neuroinflammation and promotes hippocampal neurogenesis through PPARgamma involvement. PloS One 2011, 6(12): e28668.
147. Scuderi, C., valenza, M., Stecca, C., Esposito, G., Carratu, M.R., Steardo, l. Palmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferatoractivated receptor-Alpha. J Neuroinflammation 2012, 9: 49.
148. 148.Fukasawa, H., Nakagomi, M., Yamagata, N. et al. Tamibarotene: a candidate retinoid drug for Alzheimer's disease. Biol Pharm Bull 2012, 35(8): 1206-12.
149. 149.Sperling, R.A., Aisen, P.S., Beckett, l.A. et al. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011, 7(3): 280-92.